A 68-year-old Cook Island Māori man presented to the emergency department with 4 days of fevers, bilateral leg pain, swelling and blistering, without preceding injury. He had recently returned from the Cook Islands, where he visited family.
Full article available to subscribers
A 68-year-old Cook Island Māori man presented to the emergency department with 4 days of fevers, bilateral leg pain, swelling and blistering, without preceding injury. He had recently returned from the Cook Islands, where he visited family.
His background included cardiomyopathy with an implanted cardiac resynchronisation device in situ, poorly controlled type 2 diabetes mellitus, obesity, stage 4 chronic kidney disease, gout and historic colonisation with extended-spectrum beta-lactamase–producing Escherichia coli (E. coli).
At presentation, he was hypotensive (90/56mmHg), febrile (38.2 degrees Celsius) and tachypnoeic (20/min). There was markedly tender bilateral erythema up to the proximal calves and linear erythema tracking up to the groin, consistent with cellulitis and lymphangitis. Chronic venous changes were evident bilaterally. There was no crepitus. He had generally poor skin quality in his lower limbs, as well as areas of distal paraesthesia, felt secondary to his diabetes.
Initial blood tests showed a marked inflammatory response with acute kidney injury (see Appendix Table 1).
Three sets of peripheral blood cultures were obtained pre-treatment. Broad-spectrum antibiotics were commenced (ceftriaxone, clindamycin and vancomycin) due to pain deemed out of proportion with clinical findings. However, further serial clinical review discounted the likelihood of a necrotising soft tissue infection. Overnight, all three sets of cultures isolated Gram-negative bacilli. Subsequent review by the infectious diseases team led to a recommendation to change ceftriaxone to meropenem.
On further enquiry, he denied seawater immersion or coral injury while in the Cook Islands, though he had stayed in a coastal area of an outer Cook Island. He had, however, consumed raw fish.
The blood culture isolates were subsequently identified as Shewanella algae (S. algae), susceptible to ceftazidime, ciprofloxacin, gentamicin, trimethoprim-sulfamethoxazole and piperacillin-tazobactam; antibiotic treatment was rationalised thereafter (see Appendix Table 1). The patient completed 10 days of treatment, with improving symptoms, before being discharged. Unfortunately, due to poor tissue healing in the setting of his diabetes and residual infection in his left foot, he was subsequently readmitted later that year with polymicrobial osteomyelitis of his left foot and ankle, leading to a left below-knee amputation. Intraoperative bone samples had mixed growth, including S. algae.
Unlike non-infectious cellulitis mimics such as stasis dermatitis or lipodermatosclerosis, which commonly present bilaterally,3 true bilateral cellulitis remains an uncommonly described clinical entity, with scattered case reports over the last three decades.4
Local data1,2 describe unilateral involvement in most cellulitis cases, though one retrospective study noted 16% of cases were described as bilateral;2 how these were judged to be instances of “true” bilateral cellulitis is not detailed. Prospective diagnostic aids (the ALT-70 Score for Cellulitis and the New HAvUN criteria) score against cellulitis if there is bilateral limb involvement.5
Mechanistically, it is conceivable, although unlikely, that bacterial invasion through a skin breach, leading to cellulitis,3 could occur near-simultaneously in both limbs. A more commonly implicated mechanism for bilateral cellulitis is secondary to haematogenous spread to the lower limbs from another primary site (i.e., after gastrointestinal invasion).4
Beta-haemolytic streptococci, primarily Streptococcus dysgalactiae and Streptococcus pyogenes, are the leading causes of non-purulent cellulitis.3,6 In contrast, available literature on bilateral cellulitis identifies a more diverse range of pathogens.4 Shewanella are Gram-negative bacteria found in aquatic environments.3 Most infections are caused by S. algae and Shewanella putrefaciens.7 Clinical syndromes caused by Shewanella overlap with those of Vibrio—highlighted as a cause of bilateral cellulitis4—and other environmental Gram-negative bacteria,7–9 including skin and soft tissue infections and bacteraemia.
Locally acquired Shewanella infections have only been reported twice in Aotearoa New Zealand: a case from the Bay of Plenty describes unilateral lower limb cellulitis10 after lacerations were sustained from a fishing bin in local waters, and another case from the Rotorua Lakes District11 after freshwater exposure. International literature regarding Shewanella infections in general—including skin and soft-tissue, bacteraemia, and visceral infections—describes preceding water exposure across all infectious clinical syndromes,7 though recent studies from Northern Australia8 and Hong Kong9 found this association less consistent, with the caveat of retrospective determination of water exposure from available documentation. Interestingly, contaminated seafood ingestion was posited to be an explanation for the relatively large number of cases seen in Hong Kong.9
It was thought that the likely route of infection for our patient was gut translocation of S. algae with subsequent haematogenous dissemination to the lower limbs, secondary to ingestion of raw fish. An alternative hypothesis was near-simultaneous inoculation of both lower limbs by sea or by shower water.
True bilateral cellulitis is an uncommon clinical entity, but it may occur via haematogenous dissemination or near-simultaneous inoculation of both limbs. Bilateral cellulitis should not be discounted as a cellulitis “mimic” in the presence of sepsis. Recent travel, aquatic exposure and seafood ingestion should be routinely considered risk factors for uncommon causes of cellulitis that may be resistant to standard empiric antibiotic treatment, such as Shewanella.
View Appendix.
Joachim Tan: Registered Medical Officer, Middlemore Hospital, Auckland, New Zealand.
Richard Babor: General, Upper GI and Bariatric Surgeon, Department of General Surgery, Middlemore Hospital, Auckland, New Zealand.
Tim Cutfield: Infectious Diseases and General Physician, Department of Infectious Diseases, Middlemore Hospital, Auckland, New Zealand.
We accept full responsibility for the conduct of this report and our access to the data, and we controlled the decision to publish.
Signed written consent was obtained by the corresponding author from the patient during their admission.
Joachim Tan: Department of Medicine, Middlemore Hospital, 100 Hospital Road, Auckland 2025, New Zealand.
Nil.
1) Ritchie SR, Cutfield T, Lee A, et al. The Impact of the Auckland Cellulitis Pathway on Length of Hospital Stay, Mortality Readmission Rate, and Antibiotic Stewardship. Clin Infect Dis. 2021 Sep 7;73(5):859-865. doi: 10.1093/cid/ciab181.
2) Grinlinton M, Sohn S, Hill A, et al. Clinical characteristics affecting length of stay in patients with cellulitis. ANZ J Surg. 2019 Jan;89(1-2):90-95. doi: 10.1111/ans.14413.
3) Rrapi R, Chand S, Kroshinsky D. Cellulitis: A Review of Pathogenesis, Diagnosis, and Management. Med Clin North Am. 2021 Jul;105(4):723-735. doi: 10.1016/j.mcna.2021.04.009.
4) Chuang YC, Liu PY, Lai KL, Tseng CH. Bilateral Lower Limbs Cellulitis: A Narrative Review of an Overlooked Clinical Dilemma. Int J Gen Med. 2022 Jun 9;15:5567-5578. doi: 10.2147/IJGM.S356852.
5) Edwards G, Freeman K, Llewelyn MJ, Hayward G. What diagnostic strategies can help differentiate cellulitis from other causes of red legs in primary care? BMJ. 2020 Feb 12;368:m54. doi: 10.1136/bmj.m54.
6) Taggart M, Langworthy K, Hui S, et al. Serological Responses to Streptococcus pyogenes Vaccine Candidate Antigens Suggests That Streptococcus dysgalactiae Is the Predominant Cause of Lower Limb Cellulitis. Open Forum Infect Dis. 2024 Jun 11;11(6):ofae272. doi: 10.1093/ofid/ofae272.
7) Yousfi K, Bekal S, Usongo V, Touati A. Current trends of human infections and antibiotic resistance of the genus Shewanella. Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1353-1362. doi: 10.1007/s10096-017-2962-3.
8) Campbell S, MacGregor K, Smith EL, et al. Clinical Presentation and Outcomes Following Infection With Vibrio spp, Aeromonas spp, Chromobacterium violaceum, and Shewanella spp Water-Associated Organisms in Tropical Australia, 2015-2022. Open Forum Infect Dis. 2024 Jun 12;11(7):ofae319. doi: 10.1093/ofid/ofae319.
9) Ng WW, Shum HP, To KK, Sridhar S. Emerging Infections Due to Shewanella spp.: A Case Series of 128 Cases Over 10 Years. Front Med (Lausanne). 2022 Apr 29;9:850938. doi: 10.3389/fmed.2022.850938.
10) Leung B, Meech R, Lau N, Cunliffe R. Shewanella algae causing lower limb soft tissue infection in New Zealand. N Z Med J. 2012;125:75-77.
11) Olley S. Rotorua kaumātua battles rare Shewanella bacterial infection after visiting Waiteti Stream [Internet]. Rotorua, New Zealand: Rotorua Daily Post; 2019 Feb 20 [cited 2024 Oct 20]. Available from: https://www.nzherald.co.nz/rotorua-daily-post/news/rotorua-kaumatua-battles-rare-shewanella-bacterial-infection-after-visiting-waiteti-stream/ZYRE35XTKBVDIKXDGPJJXZE7SY/
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz